Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07205289) titled 'Serum Collection Study for Assay Development' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: GPN Vaccines
Condition:
Pneumococcal Disease, Invasive
Pneumococcal Disease
Intervention:
Biological: Gamma-PN
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: October 2025
Target Sample Size: 12
Countries of Recruitment:
Australia
To know more, visit https://clinicaltrials.gov/study/NCT07205289
Published by HT Digital Content Services with permi...